1,0
22 dec 2016
Anonieme werknemer
Voormalige werknemer
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht
Pluspunten
BioTime successfully transitioned from blood products to stem cell focus at an excellent time, and attracted some strong backers with excellent resources and know-how.
Minpunten
Internal management is scattered and unfocused. CEO Mike West consistently opts for expenditures based on personal whims and self-glorification rather than overall company well-being. Rewards are rarely based on merit.